Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development

COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.

Detalles Bibliográficos
Autores principales: Shahidi Dadras, Mohammad, Rakhshan, Azadeh, Ahmadzadeh, Arman, Hosseini, Seyed Ali, Diab, Reem, Safari Giv, Toktam, Abdollahimajd, Fahimeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512177/
https://www.ncbi.nlm.nih.gov/pubmed/34667608
http://dx.doi.org/10.1002/ccr3.4931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512177/
https://www.ncbi.nlm.nih.gov/pubmed/34667608
http://dx.doi.org/10.1002/ccr3.4931

Ejemplares similares